Aimmune Therapeutics Inc (AIMT) short interest is $167 million; 6.90 million shares shorted; 18.09% of float; stock borrow cost is 30 bps fee (general collateral).
AIMT shares shorted have been relatively stable in 2019, up only 259k, +3.90% in 2019. But we saw an steady increase in February, with 356k shares shorted, a 5.44% increase.